Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» August 2013
August 2013
Teva-Rexahn Deal Terminated - Analyst Blog
Teva-Rexahn Deal Terminated - Analyst Blog
NASDAQ
Teva
Rexahn
RX-3117
Teva Final Phase III Study of Armodafinil Did Not Meet Primary Endpoints
Teva Final Phase III Study of Armodafinil Did Not Meet Primary Endpoints
Street Insider
Teva
NUVIGIL
bipolar disorder
Teva Announces Over-The-Counter Availability of Plan B One-Step (levonorgestrel) tablet 1.5 mg for All Consumers
Teva Announces Over-The-Counter Availability of Plan B One-Step (levonorgestrel) tablet 1.5 mg for All Consumers
Lifescience Online
Teva
Plan B contraceptive
contraceptives
How Congress Encourages Shortages Of Cancer Drugs
How Congress Encourages Shortages Of Cancer Drugs
Forbes
cancer
Hundreds of Fosamax lawsuits vs. Merck ordered readied for trial
Hundreds of Fosamax lawsuits vs. Merck ordered readied for trial
Reuters
Merck
Fosamax
lawsuits
The Non-FDA Agency That Could Change Drug Development Forever
The Non-FDA Agency That Could Change Drug Development Forever
Motley Fool
Centers for Medicare and Medicaid Services
Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue
Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue
Seeking Alpha
Eli Lilly
necitumumab
lung cancer
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio (teriflunomide)
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio (teriflunomide)
Yahoo/BusinessWire
Genzyme
multiple sclerosis
Aubagio
MS
Should Novartis Shareholders Be Worried About This?
Should Novartis Shareholders Be Worried About This?
Motley Fool
Novarits
Gilenya
progressive multifocal leukoencephalopathy
Gilead Sues Merck Saying New Drug Won’t Infringe Patents
Gilead Sues Merck Saying New Drug Won’t Infringe Patents
Seeking Alpha
patents
Merck
lawsuits
Gilead Sciences
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »